2023 | Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC | Kim, Hye Ryun; Awad, Mark M; Navarro, Alejandro; Gottfried, Maya; Peters, Solange; Csőszi, Tibor; Cheema, Parneet K; Rodriguez-Abreu, Delvys; Wollner, Mirjana; CHIH-HSIN YANG ; Mazieres, Julien; Orlandi, Francisco J; Luft, Alexander; Gümüş, Mahmut; Kato, Terufumi; Kalemkerian, Gregory P; Luo, Yiwen; Santorelli, Melissa L; Pietanza, M Catherine; Rudin, Charles M | JTO clinical and research reports | 1 | 0 | |
2023 | Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations | Sequist, Lecia V; CHIH-HSIN YANG ; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 8 | 34 | |